Table 1.

Description of studies excluded in review

N	Author/Country	Population/Study design	Reasons for exclusion
1	Shalhoub 2015 Saudi Arabia	A patient with MERS-CoV/HIV co-infection/case study	TB status was not reported
2	Bogorodckaya 2020 Russia	three TB patients co-infected with COVID-19/ case study	Cases were incompletely reported.
3	Wang 2020 China [26]	A patient with COVID-19/HIV co-infection/case report	TB status was not reported
4	Zhu 2020 China	A patient with COVID-19/HIV co-infection/case report	TB status was not reported
5	Zhao 2020 China	A patient with COVID-19/HIV/HCV co-infection/ case report	TB status was not reported
6	Baluku 2020 Uganda	A patient with COVID-19/HIV co-infection /case report	TB status was not reported
7	Blanco 2020 Spain	Five cases of COVID-19/HIV co-infection/ clinical case series	None reported TB status
8	Riva 2020 Italy	Three cases with COVID-19/HIV co-infection / case series	None reported TB status
9	Aydin 2020 Turkey	Three patients with COVID-19/HIV co-infection /case series	Outcomes of interest were not reported
10	Benkovic 2020 USA	Four patients with COVID-19/HIV Co-infection/Case series	Outcomes of interest were not reported
11	Haddad 2020 USA	A case with COVID-19/HIV co-infection/Case report	TB screening was not reported
12	Gervasoni 2020 Italy	47 COVID-19/HIV co-infected patients Retrospective study	Outcomes of interest were not reported
13	Wang 2020 China [26]	A patient with COVID-19/HIV Co-infection/Case report	TB status was not reported
14	Härter 2020 Germany	33 COVID-19/HIV co-infected patients Retrospective study	Outcomes of interest were not reported
15	Wu 2020 China	Two patients with COVID-19/HIV co-infection/Case series	TB screening was not reported
16	Del 2020 Spain [27]	77,590 COVID/HIV co-infected cases	Outcomes of interest were not reported
17	Bulled 2020 South Africa	Comment on COVID-19/HIV/TB co-infection	This was a commentary
18	Tadolini 2020 Italy	49 patients with COVID-19/TB co-infection	Duplicate report from the same cohort
19	Chen 2020 China [28]	COVID-19/TB burden	Letter to the editor without case report
20	Drain 2020 USA	Explanatory article on COVID/HIV burden	TB screening was not reported
21	Karim 2020 USA	Included percentage of COVID-19/HIV/TB report	No primary data reported
22	Pang 2020 China	Included COVID-19/TB cases	A correspondence
23	Wang 2020 China [26]	A case of COVID-19/HIV co-infection	The outcomes of interest were not reported
24	Kilds 2020 USA	A case of COVID-19/HIV co-infection	The outcomes of interest were not reported
25	Ridgway 2020 USA	A case series of five COVID-19/HIV co-infection	Had no outcome of interest reported
26	Sigel 2020 USA	Eighty eight COVID-19/HIV co-infection	Had no outcome of interest reported
27	Patel 2020 USA	A case study of COVID-19/HIV co-infection	The interest outcome was not reported
28	Guo 2020 China	A survey among COVID-19/HIV co-infected cases	The interest outcome was not reported
29	Shalev 2020 USA	31 patients with COVID-19/HIV co-infection	The outcomes of interest were not reported
30	Karmen-Tuohy 2020 USA	A case control of 21 patients COVID-19/HIV co-infection	The outcomes of interest were not reported
31	Toombs 2020 United Kingdom	Three Cases with COVID-19/HIV co-infection	Do not contain the outcome of interest
32	Ruan 2020 China	Three cases with COVID-19/HIV co-infection	Had no outcome of interest reported
33	Sun 2020 Singapore	A case of SARS-2/HIV co-infection	Had no outcome of interest reported
34	Richardson 2020 USA	43 cases of SARS-2/HIV co-infection	Do not contain the outcome of interest
35	Ho 2020 USA	93 cases of SARS-s/HIV co-infection	The outcomes of interest were not reported
36	Su 2020 China	Two cases with SARS-2/AIDS co-infection	The outcomes of interest were not reported
37	Kumar India	A case of COVID-19/HIV co-infection	Had no outcome of interest reported